AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05660824 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Plattelet Rich Plasma infiltration
Description: Procedure to prepare PRP: 15 cm of peripheral blood obtained by venipuncture are centrifugated at 5000 RPM during 5 minutes. Using PRP Arthrex kit platelets poor plasma is discarded and 1-3 mm of PRP are ready to be injected
Study NCT06016985 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: caffeine gum
Description: This study investigated the effects of chewing 3 mg/kg of caffeinated gum on basketball free throw accuracy and basketball -specific performance.
Study NCT06016985 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: caffeine gum
Description: This study investigated the effects of chewing 3 mg/kg of caffeinated gum on basketball free throw accuracy and basketball -specific performance.
Study NCT05442606 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ultrasound Therapy
Description: Using an Enraf Nonius Sonoplus 490 from the Netherlands, the patients were asked to lie supine while the therapist stood at the level of the patient's head. The patients received pulsed (duty cycle 50%) US therapy with intensities of 1 and 0.5 W/cm2 for maxillary and frontal sinus, respectively, and a collimating beam frequency of 1MHz. To deliver US to the treatment area, a small probe US applicator (0.8 cm2) with an effective radiating area (ERA) of 0.6 cm2 and a beam non-uniformity ratio (BNR) of 6:1 was used. The skin around the cheeks was used for the maxillary sinus and the forehead for the frontal sinus. Between the applicator and the skin, ultrasound transmission gel was employed, and a full contact technique in slow circular motion was used for 5 minutes over the maxillary sinuses and 4 minutes over the frontal sinuses on each pair of sinuses
Study NCT05442606 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Manual Drainage Techniques
Description: Manual Drainage Techniques for the frontal and maxillary sinuses
Study NCT05442606 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Self Sinus Massage Technique
Description: Patients will also encouraged to self-massage their frontal and maxillary sinuses while resting supine
Study NCT05679817 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dose-graded aerobic exercises
Description: The D-GAE group received a 12-week aerobic training, three times in addition to the traditional physical rehabilitation. The D-GAE program commenced with a training intensity corresponding to 50% of the maximum age-predicted heart rate for 25 minutes in the first two weeks, which progressed on a two-week basis, and ended up with a training intensity corresponding to 75% of the maximum age-predicted heart rate for 50 minutes in the last two weeks. The D-GAE program included a warm-up for 5 minutes and a cool-down for 5 minutes
Study NCT05679817 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional physical rehabilitation
Description: The control group received the traditional physical rehabilitation only, 45 minutes per session, three times a week for 12 consecutive weeks. The program consisted of flexibility exercises, strengthening exercises, balance training, and general conditioning exercises.
Study NCT05259384 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Robotic pancreaticoduodenectomy
Description: The Intervention of MIPD-ROB group
Study NCT05259384 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laparoscopic pancreaticoduodenectomy
Description: The Intervention of MIPD-LAP group
Study NCT05259384 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Robotic Distal Pancreatectomy
Description: The Intervention of MIDP-ROB group
Study NCT05259384 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laparoscopic Distal Pancreatectomy
Description: The Intervention of MIDP-LAP group
Study NCT05171634 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DiscoveryTM
Description: Colonoscopy assisted by an artificial intelligence system (DiscoveryTM).
Study NCT05171634 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: iSCAN
Description: Virtual colonoscopy assisted by iSCAN
Study NCT05073354 — intervention group
Intervention type: DEVICE
Intervention: Full SWOT Model
Description: Bundle of care that includes devices such as X Series monitor/defibrillator, AutoPusle automated compression device, Z Vent ventilator, and IPR therapies as well as bedside monitoring and diagnostics and training on a standardized care process.
Study NCT05240469 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Automated sperm selection software
Description: The software measures both morphology and motility similar to an embryologist but provides a more accurate and consistent measure of sperm characteristics. Embryologists use their experience to qualitatively judge if an individual sperm is suitable for injection based on morphology and motility. Similarly, the software follows a two-step process: firstly, a computer vision algorithm measures characteristics of all sperm in a given field, including motility and morphology; secondly, the software algorithm then uses a set of quantitative criteria to categorize and identify the most developmentally competent sperm with normal characteristics. All the characteristics that the software calculate are defined by the WHO guidelines, and the software does not propose or define new parameters.
Study NCT05233098 — intervention group
Intervention type: DEVICE
Intervention: Technetium-99m macroaggregated albumin (Tc-99m MAA)
Description: Patients who are being evaluated for TheraSphere administration.
Study NCT06255912 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LTC004 + MIL-97
Description: Dose group 1：MIL97:0.2mg/kg,Day1,Q3W,LTC004:90ug/kg,Day3,Q3W Dose group 2:MIL97:0.2mg/kg,Day1,Q3W,LTC004:180ug/kg,Day3,Q3W Dose group -1:MIL97:0.2mg/kg,Day1,Q3W,LTC004:45ug/kg,Day3,Q3W
Study NCT06255912 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LTC004 + MIL-97+chemotherapy
Description: LTC004 + MIL-97+chemotherapy
Study NCT06080906 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: IRV on a 0- and 28-day schedule
Description: Inactivated Rotavirus vaccine (Vero Cells) of 320EU/0.5ml on Day 0, 28
Study NCT06080906 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: IRV on a 0-, 28- and 56-day schedule
Description: Inactivated Rotavirus vaccine (Vero cell) of 320EU/0.5ml on Day 0, 28, 56
Study NCT06080906 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo on Day 0, 28
Description: Two doses of placebo at the vaccination schedule of Day 0, 28
Study NCT04816708 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: LIFT Mindfulness
Description: Mindfulness is a type of mind-body therapy that promotes a practice of non-judgmental awareness that can alleviate distress by uncoupling emotional reactions and habitual behavior from unpleasant symptoms, thoughts, and emotions. LIFT is a mobile mindfulness app which can assess levels of emotional distress via survey, and subsequently offer mindfulness content that has previously been used in ICU patients, where it was shown to reduce symptoms of depression, anxiety, and PTSD.
Study NCT05906901 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Cranial listening technique
Description: 5 minutes
Study NCT05906901 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Suboccipital muscles inhibition technique
Description: 6 minutes
Study NCT06074445 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT05762081 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Disposable Wipes for wiping baths
Description: A disposable wipe bath is a type of bath that is applied to bed-bound or unconscious patients and weak individuals by wiping the entire body.
Study NCT05762081 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Traditional bed bath
Description: Traditional bed bathing is a type of bathing applied to bed-bound or unconscious patients and weak individuals by wiping the entire body with soap and water.
Study NCT06080906 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo on Day 0, 28, 56
Description: Three doses of placebo at the vaccination schedule of Day 0, 28, 56
Study NCT06071182 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Task-oriented Fruit ninja game
Description: The fruit ninja game were played from tablet PC 20 minutes in a day and 2 times in a week for 4 weeks
Study NCT06071182 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: sham-controlled therapy
Description: The fruit ninja game playing video (https://www.youtube.com/watch?v=cAb0cAviA1s) was watched on the same tablet for 3 minutes a day, twice a week, for 4 weeks, and the wrist and wrist exercises were repeated for 2 minutes on a flat and smooth table. movements were made.
Study NCT03643367 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Description: Included patients, randomized in experimental group, intravenous sedation will be interrupted and followed by a 4 hour sedation with the volatile anesthetic sevoflurane.
Study NCT03643367 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Control Group
Description: Included patients randomized in control group, intravenouse sedation is continued with propofol
Study NCT05531448 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: two way texting
Description: Automated 2WT-based adherence support messages combined with scheduled visit reminders focus on preventing visit default will be implemented. One-way blast motivational support messages will be sent to all new ART patients who opt-into 2WT. ART visit reminders 3- and 1- day before visits will ask clients to respond with 1=attend and 0=no, triggering 2wT responses to clients to reschedule visits, record transfers, etc. 2WT clerks proactively communicate with clients before a visit to prevent default or ascertain true outcomes for those who don't return. Those who miss visits receive additional 2wT reminders. On day 14 post visit, 2wT patients who missed visits, did not respond to text or did not have outcomes updated (transfer, stop, etc.), are identified by the 2WT system and referred to B2C for tracing, days or months earlier than routine B2C. The 2wT-generated tracing list is more timely and accurate, reducing workload and increasing B2C effectiveness
Study NCT06479551 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: high intensity-low volume resistance training
Description: 13 participants will be in experimental group giving them High intensity-low volume resistance training protocol of 4 reps and 2 sets comprising 90% of 1 RM parallel back squats for six weeks measure all values before giving them protocol and after protocol.
Study NCT06479551 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Moderate intensity-high volume resistance training
Description: 13 participants will be in control group giving them Moderate intensity-high volume resistance training of 8 reps and 3 sets comprising 80% of 1 RM parallel back squats for six weeks measure all values before giving them protocol and after protocol.
Study NCT06640998 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Matrix Pro
Description: Study subjects received up to three (3) study treatments with the Matrix Pro applicator
Study NCT04645953 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: 3mg AZ-010
Description: Subject will receive a single inhaled dose (3mg)
Study NCT04645953 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: 1mg AZ010
Description: Subject will receive a single inhaled dose (1mg)
Study NCT04645953 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Staccato Placebo
Description: Subject will receive a single inhaled dose (Staccato Placebo)
Study NCT05319002 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group EMDR
Description: The eight phases of the adapted group EMDR protocol was administered during each session: 1. Meeting: Explaining the nature of trauma, group rules, name tags, filling in the scales. 2. Preparation: Exploring children's support system, explaining EMDR, safe place, resource exercise, and installation with bilateral stimulation (BLS, butterfly hug or knee tapping). 3. Assessment: Drawing the worst image on a small separate sheet of paper, SUD level, (negative cognition, emotions, body sensations - if possible). 4. Desensitization: It is done with drawing on 4 separate papers with BLS (butterfly hug or knee tapping). 5. Installation: With the healing story written according to the adaptive information processing (AIP) model, the installation is accompanied BLS. 6. Body scan: A positive body state is installed with the relaxation technique. 7. Closure \& future template: Strong closure with artwork. 8. Re-evaluation: if possible.
Study NCT05131711 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Combined stereotactic radiosurgery and enhanced immunotherapy
Description: Patients will be administrated immunal adjuvants intratumorally and systemically with concurrent stereotactic radiosurgery.
Study NCT05199441 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dihydroxydibutylether group
Description: This group takes 1.500 mg/day of dihydroxydibutylether for 8 weeks.
Study NCT05199441 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Control group placebo
Description: This group takes 1,500 mg/day of placebo for 8 weeks.
Study NCT04165525 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ablation
Description: comparison of using an argon gas and high frequency electrical current ablation device with a standard Bovie electrosugical device without argon gas.
Study NCT05513950 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CHF10067 starting dose
Description: Intravenous administration of a starting dose of the monoclonal antibody
Study NCT05513950 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CHF10067 intermediate dose
Description: Intravenous administration of an intermediate dose of the monoclonal antibody
Study NCT05513950 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CHF10067 high dose
Description: Intravenous administration of a high dose of the monoclonal antibody
Study NCT05513950 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Intravenous administration of a physiological solution as placebo.
Study NCT05060237 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: BF-200 ALA and red light LED lamp
Description: Photodynamic therapy (PDT) using BF-RhodoLED® XL (ALA-PDT, Ameluz®-PDT):~Topical application of 3 tubes BF-200 ALA on the expanded treatment field (60 cm²), followed by red light illumination with BF-RhodoLED® XL after 3 h incubation of study medication under light-tight, occlusive dressing.
Study NCT05418868 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cabotegravir 200 mg/mL
Description: CAB 200 mg/mL will be administered.
Study NCT05418868 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cabotegravir >=400 mg/mL
Description: CAB >=400 mg/mL will be administered by IM or SC injection.
Study NCT05531305 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Muscle ultrasound
Description: Standardized ultrasonographic measurement of quadriceps muscle layer thickness.
Study NCT05531305 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Indirect calorimetry
Description: Non-invasive measurement of resting energy expenditure using the Q-NRG metabolic monitor with hood and canopy.
Study NCT05531305 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Hand dynamometry
Description: Assessment of handgrip strength using hand dynamometry.
Study NCT05531305 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: MRC Sum Score
Description: Assessment of muscle function/limb strength using the Medical Research Council sum score (12-60 points).
Study NCT05659511 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: MRI
Description: MRI data was acquired with a GE discovery MR750 3.0 T scanner using an eight-channel phased- array head coil. Foam padding was used to restrict head movement and ear plugs were used to eliminate scanner noise. During the acquisition period, all participants were asked to keep their eyes closed and not to think anything.
Study NCT01825083 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketamine
Description: Ketamine group receives 0.5mg/kg followed by an infusion of 1.5mcg/kg/min.
Study NCT01825083 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0.9 % normal saline group receives same volume as the ketamine dose
Study NCT05278338 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JMT103
Description: subcutaneous injection, once every 6 months (Q6M), with a total of 2 administrations
Study NCT05278338 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Denosumab
Description: subcutaneous injection, once every 6 months (Q6M), with a total of 2 administrations
Study NCT05278338 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: subcutaneous injection, once every 6 months (Q6M), with a total of 2 administrations
Study NCT05044949 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Probiotic
Description: The study product is a probiotic strain
Study NCT05044949 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The study product is a placebo to the probiotic strain
Study NCT05309473 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Philips SmartSleep Acoustic Stimulation Device
Description: Prior to bedtime on the first two recovery nights, a Philips SmartSleep device will be applied to the head of each subject. Subjects will receive acoustic stimulation during the four hours of sleep.
Study NCT05309473 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham (no Acoustic Stimulation)
Description: Prior to bedtime on the first two recovery nights, a Philips SmartSleep device will be applied to the head of each subject. Subjects will receive Sham (no acoustic stimulation) during the four hours of sleep.
Study NCT06090617 — intervention group
Intervention type: PROCEDURE
Intervention: Skin Biopsy
Description: Skin biopsies were obtained in all recruited patients.
Study NCT06090617 — intervention group
Intervention type: PROCEDURE
Intervention: Video-laparoscopic adrenalectomy
Description: Video-laparoscopic adrenalectomy in those with unilateral PA. (PA group 1)
Study NCT04895813 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Education
Description: The patient will be given pre-colonoscopy training and guidance by telephone.
Study NCT05125913 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: FMD
Description: Measurements will be made by using ultrasound system with a 12-Mhz probe. All vasoactive medications will be withheld for 24 h before the procedure. The participants will remain at rest in the supine position for at least 15 minutes before the examination. Each subject's right arm will be comfortably immobilized in the extended position to allow consistent recording of the brachial artery 2-4 cm above the antecubital fossa. If an arteriovenous fistula is present, the contralateral arm will be used for assessment. Three adjacent measurements of end-diastolic brachial artery diameter will be made from single 2D frames. The maximum FMD diameters will be calculated as the average of the three consecutive maximum diameter measurements after hyperemia and nitroglycerin, respectively.
Study NCT05125913 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Arterial stiffness
Description: Arterial stiffness assessment will be performed by applanation tonometry with the patient being recumbent, 10 minutes before the measures were done. The carotid and femoral pulse will be acquired by applanation tonometry sequentially, allowing a single operator to acquire the measurement. The transit time from the R-wave of the simultaneously acquired electrocardiogram to the foot of the carotid and femoral pulse is measured. The difference-acquired electrocardiogram to the foot of the carotid and femoral pulse is measured. The difference between these 2 transit times is divided by distances measured from the body surface to estimate the arterial path length in order to calculate carotid-femoral PWV.
Study NCT05125913 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Assessment of IMT
Description: A high-resolution B-mode ultrasound of the common carotid arteries with scanning of the longitudinal axis until the bifurcation and of the transversal axis will be performed using ultrasonic pulse with a middle frequency of 12 MHz. For each carotid artery, two longitudinal measurements will be obtained by rotating the vessels at 180o increments along their axis. IMT will be measured at 1 cm proximal to the bifurcation on each side.
Study NCT05125913 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Echocardiography
Description: Echocardiography will be performed on each patient at baseline; the measurements will be carried out according to the recommendations of the American Society of Echocardiography by an observer unaware of the lung ultrasound and bioimpedance results. Echocardiographic evaluation will provide information about cardiac anatomy (e.g. volumes, geometry, mass) and function (e.g. left ventricular function and wall motion, valvular function, right ventricular function, pulmonary artery pressure, pericardium).